» Articles » PMID: 24042491

Incidence of Dementia with Lewy Bodies and Parkinson Disease Dementia

Overview
Journal JAMA Neurol
Date 2013 Sep 18
PMID 24042491
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Epidemiologic data on dementia with Lewy bodies (DLB) and Parkinson disease dementia (PDD) remain limited in the United States and worldwide. These data are essential to guide research and clinical or public health interventions.

Objective: To investigate the incidence of DLB among residents of Olmsted County, Minnesota, and compare it with the incidence of PDD.

Design: The medical records linkage system of the Rochester Epidemiology Project was used to identify all persons who developed parkinsonism and, in particular, DLB or PDD from 1991 through 2005 (15 years). A movement disorders specialist reviewed the complete medical records of each suspected patient to confirm the diagnosis.

Setting: Olmsted County, Minnesota, from 1991 through 2005 (15 years).

Participants: All the residents of Olmsted County, Minnesota, who gave authorization for medical record research.

Main Outcomes And Measures: Incidence of DLB and PDD.

Results: Among 542 incident cases of parkinsonism, 64 had DLB and 46 had PDD. The incidence rate of DLB was 3.5 per 100,000 person-years overall, and it increased steeply with age. The incidence of PDD was 2.5 overall and also increased steeply with age. The incidence rate of DLB and PDD combined was 5.9. Patients with DLB were younger at onset of symptoms than patients with PDD and had more hallucinations and cognitive fluctuations. Men had a higher incidence of DLB than women across the age spectrum. The pathology was consistent with the clinical diagnosis in 24 of 31 patients (77.4%) who underwent autopsy.

Conclusions And Relevance: The overall incidence rate of DLB is lower than the rate of Parkinson disease. The incidence of DLB increases steeply with age and is markedly higher in men. This men to women difference may suggest different etiologic mechanisms. Our findings may guide health care planning and prompt new studies.

Citing Articles

Determinants of Sexual Dysfunction in Parkinson's Disease Patients: A Secondary Analysis of a Multicenter Cross-Sectional Study.

Manuli A, Maggio M, de Pasquale P, Raciti L, Filoni S, Portaro S J Clin Med. 2025; 14(1.

PMID: 39797235 PMC: 11721904. DOI: 10.3390/jcm14010152.


Advances in the Neuro-Rehabilitation of Parkinson's Disease: Insights from a Personalized Multidisciplinary Innovative Pathway.

Maggio M, Bonanno M, Manuli A, De Luca R, Di Lorenzo G, Quartarone A Biomedicines. 2024; 12(11).

PMID: 39594993 PMC: 11591689. DOI: 10.3390/biomedicines12112426.


The association between cigarette smoking and dementia with Lewy bodies.

Goodheart A, Gomperts S Parkinsonism Relat Disord. 2024; 128:107133.

PMID: 39276722 PMC: 11663461. DOI: 10.1016/j.parkreldis.2024.107133.


End-of-Life Healthcare Utilization in Lewy Body Dementia.

Alipour-Haris G, Armstrong M, Goodin A, Guo J, Brown J J Alzheimers Dis. 2024; 101(1):133-145.

PMID: 39121116 PMC: 11371273. DOI: 10.3233/JAD-240194.


Association of Terazosin, Doxazosin, or Alfuzosin Use and Risk of Dementia With Lewy Bodies in Men.

Hart A, Aldridge G, Zhang Q, Narayanan N, Simmering J Neurology. 2024; 103(2):e209570.

PMID: 38896813 PMC: 11226317. DOI: 10.1212/WNL.0000000000209570.


References
1.
Perez F, Helmer C, Dartigues J, Auriacombe S, Tison F . A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort. J Neurol Neurosurg Psychiatry. 2009; 81(7):742-6. DOI: 10.1136/jnnp.2009.189142. View

2.
Frigerio R, Sanft K, Grossardt B, Peterson B, Elbaz A, Bower J . Chemical exposures and Parkinson's disease: a population-based case-control study. Mov Disord. 2006; 21(10):1688-92. DOI: 10.1002/mds.21009. View

3.
Chung S, Armasu S, Biernacka J, Lesnick T, Rider D, Cunningham J . Variants in estrogen-related genes and risk of Parkinson's disease. Mov Disord. 2011; 26(7):1234-42. PMC: 4723424. DOI: 10.1002/mds.23604. View

4.
Okazaki H, LIPKIN L, Aronson S . Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol. 1961; 20:237-44. DOI: 10.1097/00005072-196104000-00007. View

5.
de Rijk M, Tzourio C, Breteler M, Dartigues J, Amaducci L, Lopez-Pousa S . Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997; 62(1):10-5. PMC: 486688. DOI: 10.1136/jnnp.62.1.10. View